Abstral
NDC 42747-221
Product Information
Abstral is a NDA-approved product labeled by Prostrakan, Inc.. This medication is used to help relieve sudden (breakthrough) pain in people who are already taking opioid medication around-the-clock for cancer pain. It is supplied as a blue product. This product entry covers the primary NDC 42747-221 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
1
Code Structure Chart
Product Details
What is NDC 42747-221?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- FENTANYL CITRATE (UNII: MUN5LYG46H)
- FENTANYL (UNII: UF599785JZ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MANNITOL (UNII: 3OWL53L36A)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1053647 - fentaNYL 100 MCG Sublingual Tablet
- RxCUI: 1053647 - fentanyl 0.1 MG Sublingual Tablet
- RxCUI: 1053647 - fentanyl (as fentanyl citrate) 100 MCG Sublingual Tablet
- RxCUI: 1053651 - ABSTRAL 100 MCG Sublingual Tablet
- RxCUI: 1053651 - fentanyl 0.1 MG Sublingual Tablet [Abstral]
* Please review the full disclaimer at the bottom of this page.